Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10613	Companies
225274	Keywords
153914	Articles
119193	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 05/13/2025 at 18:00, 1 year 1 month ago

THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE RÉELLE TRÈS POSITIVES SOUTENANT L'EFFICACITÉ DE BATTEN-1 DANS LE TRAITEMENT DE LA MALADIE DE BATTEN CLN3
Theranexus et la Fondation Beyond Batten Disease présentent des résultats prometteurs pour le traitement de la maladie de Batten-CLN3 avec le médicament Batten-1 (miglustat). Nouvelle étude en vie réelle montre une préservation de l'acuité visuelle

Theranexus Batten-1 Miglustat Fondation Beyond Batten Disease Traitement CLN3
PRESS RELEASE

published on 05/13/2025 at 18:00, 1 year 1 month ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
BRIEF

published on 04/29/2025 at 19:05, 1 year 1 month ago

Theranexus : Bilan Annuel 2024 et Nouvelles Perspectives

Résultats Financiers Partenariats Theranexus Batten-1 Subventions
BRIEF

published on 04/29/2025 at 19:05, 1 year 1 month ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 1 year 1 month ago

THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Theranexus publie ses résultats annuels 2024, fait le point sur ses activités et clôture sa ligne de financement. Détails sur Batten-1, PickASO, IMASO et partenariat avec Exeltis

Résultats Annuels Theranexus Batten-1 PickASO Exeltis
PRESS RELEASE

published on 04/29/2025 at 19:00, 1 year 1 month ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 1 year 3 months ago

Modification du contrat de liquidité de Theranexus

Contrat De Liquidité AMF PORTZAMPARC Theranexus Maladies Neurologiques Rares
BRIEF

published on 03/06/2025 at 18:05, 1 year 3 months ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
PRESS RELEASE

published on 03/06/2025 at 18:00, 1 year 3 months ago

MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Theranexus annonce une modification de contrat de liquidité afin de se conformer à la réglementation. Retrait de 50 000 euros. Bilan du 31/12/2024 et présentation de la société

Contrat De Liquidité Réglementation Theranexus Neurologie Batten
BRIEF

published on 01/31/2025 at 18:10, 1 year 4 months ago

Bilan semestriel du contrat de liquidité de Theranexus avec Portzamparc

Contrat De Liquidité Bilan Semestriel Transactions PORTZAMPARC Theranexus

Accesswire

Published on 06/22/2026 at 15:58, 1 hour 48 minutes ago

Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 2 hours 16 minutes ago

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 2 hours 46 minutes ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 3 hours 45 minutes ago

Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 3 hours 46 minutes ago

Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 17:35, 10 minutes ago

Heidrick & Struggles Strengthens Board with Appointment of AI and Talent Leaders Aseem Datar and Leanne Wood
Published on 06/22/2026 at 16:29, 1 hour 16 minutes ago

Holding(s) in Company
Published on 06/22/2026 at 16:21, 1 hour 24 minutes ago

Fuller, Smith & Turner PLC: Share Buyback Programme
Published on 06/22/2026 at 16:05, 1 hour 40 minutes ago

ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 2 hours 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc

Les Echos

Published on 06/22/2026 at 14:42, 3 hours 3 minutes ago

COMMUNIQUE HOPENING 22 juin 2026
Published on 06/22/2026 at 08:30, 9 hours 16 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 9 hours 16 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 22 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 22 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026

View all LES ECHOS COMFI WIRE